Pfizer vaccine destroys T cells, weakens the
immune system – study
Sunday, August 22, 2021 by: Arsenio Toledo
Tags: badhealth, badmedicine, badscience, coroanvirus, coronavirus vaccines, covid-19, immune health, immune system, immunity, immunosuppressed, Pfizer, Pfizer vaccines, T-cells, Vaccine dangers, Vaccine injuries, vaccines
13KVIEWS
(Natural News) A study from the Francis Crick Institute in the United Kingdom has
found that the Pfizer-BioNTech Wuhan coronavirus (COVID-19) vaccine destroys T cells and
weakens the immune system. But
pharmaceutical corporations are trying to suggest that the only way to prevent
this from happening is for people to get third or booster doses of their
vaccines.
T cells are immune cells
that can focus on targeting specific foreign
particles. They are
most commonly studied in relation to their ability to fight cancer and
infectious diseases, but they are also essential for other aspects of the
body’s immune response.
There are two kinds of T
cells: killer T cells and
helper T cells. Killer T
cells directly attack cells that have already been infected by foreign
particles. Helper T cells aid other cells to develop killer cells and stimulate
other cells to create neutralizing antibodies.
This study from the Francis
Crick Institute focuses on the neutralizing antibodies created by T cells. It
analyzes whether the Pfizer vaccine helps the T cells create enough antibodies
to fight off the COVID-19 variants.
Pfizer
vaccine barely produces antibodies to fight against COVID-19
The Francis Crick
Institute, in collaboration with the British National Institute for
Health Research, released a study that showed that the Pfizer-BioNTech
COVID-19 vaccine produced fewer
neutralizing antibodies against
COVID-19’s variants. (Related: Spanish study finds
Pfizer vaccine contains high levels of TOXIC graphene oxide.)
The scientists analyzed the
antibodies from the blood of 250 healthy adults who have received either one or
two doses of the Pfizer-BioNTech vaccine up to three months after their first
dose.
The researchers used a test
specially developed by the Francis Crick Institute to figure out the ability of
the neutralizing antibodies to prevent the entry of the COVID-19 variants.
It found that only 50
percent of the people who received a single dose of the Pfizer vaccine had a
quantifiable neutralizing antibody response against the alpha variant of
COVID-19. This number decreased even further to just 32 percent and 25 percent
for the delta and beta variants, respectively.
The situation gets worse
for older individuals who have weaker immune systems. The researchers found
that older vaccine recipients generated even fewer antibodies. Coupled with the
vaccine’s ability to destroy T cells and weaken the immune system even further,
getting vaccinated could spell disaster for many people.
No correlation was observed
for gender or body mass index. The authors of the study want to pursue further
studies to check the capabilities of other vaccines, starting with the
Oxford-AstraZeneca vaccine.
“So, the key message from
our finding is we found that recipients of the Pfizer vaccine, those who have
had two doses, have about five- to six-fold lower amounts of neutralizing
antibodies,” said David Bauer, head of the Bauer Lab in the Francis Crick
Institute. He
continued:
“Now, these are the, sort
of, gold standard, private security antibodies of your immune system which
block the virus from getting into your cells in the first place. So, we’ve
found that that is less for people with two doses. We also found that for
people with only one dose of the Pfizer jab that they are less likely to have
high levels of these antibodies in their blood.”
Instead of recommending
that people stay away from the COVID-19 vaccines to protect their natural
immune systems, Bauer instead said people should get booster doses of the
vaccines. He also said older people should be prioritized in the distribution
of booster doses.
“And perhaps most
importantly for all of us going forward is that we see that the older you are,
the lower your levels are likely to be. And the time since you’ve had your
second jab, as that time goes on, the lower your levels are also likely to be,”
he said. “So, that’s telling us that we are probably going to be needing to
prioritize boosters for older and more vulnerable people.”
Learn more about the
inability of the COVID-19 vaccines to prevent coronavirus infections and the
push for booster doses by reading the latest articles at Vaccines.news.
Sources
include:
